Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anthony El-Khoueiry
SWOG Cancer Research Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
141 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the University of Arizona Medical Center-University Campus
Tucson, Arizona, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- Sutter Cancer Research Consortium
Novato, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Valley Medical Oncology Consultants
Pleasanton, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Poudre Valley Hospital
Fort Collins, Colorado, United States
- Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States
- Uf Cancer Center at Orlando Health
Orlando, Florida, United States
- Northeast Georgia Medical Center
Gainesville, Georgia, United States
- Memorial University Medical Center
Savannah, Georgia, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Oncare Hawaii Inc-Kuakini
Honolulu, Hawaii, United States
- Oncare Hawaii Inc-Pob Ii
Honolulu, Hawaii, United States
- Queen'S Medical Center
Honolulu, Hawaii, United States
- Straub Clinic and Hospital
Honolulu, Hawaii, United States
- the Cancer Center of Hawaii-Liliha
Honolulu, Hawaii, United States
- University of Hawaii Cancer Center
Honolulu, Hawaii, United States
- Maui Memorial Medical Center
Wailuku, Hawaii, United States
- Pali Momi Medical Center
‘Aiea, Hawaii, United States
- Central Illinois Ccop
Decatur, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Memorial Medical Center
Springfield, Illinois, United States
- Saint Francis Hospital and Health Centers
Beech Grove, Indiana, United States
- Reid Hospital and Health Care Services
Richmond, Indiana, United States
- Cancer Center of Kansas - Chanute
Chanute, Kansas, United States
- Cancer Center of Kansas - Dodge City
Dodge City, Kansas, United States
- Cancer Center of Kansas - El Dorado
El Dorado, Kansas, United States
- Cancer Center of Kansas - Fort Scott
Fort Scott, Kansas, United States
- Cancer Center of Kansas-Independence
Independence, Kansas, United States
- Cancer Center of Kansas-Kingman
Kingman, Kansas, United States
- Lawrence Memorial Hospital
Lawrence, Kansas, United States
- Cancer Center of Kansas-Liberal
Liberal, Kansas, United States
- Cancer Center of Kansas - Newton
Newton, Kansas, United States
- Menorah Medical Center
Overland Park, Kansas, United States
- Saint Luke'S South Hospital
Overland Park, Kansas, United States
- Cancer Center of Kansas - Parsons
Parsons, Kansas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2010
- Primary completion
- 30 Sept 2012
- Completion
- 30 Sept 2014
- Last update posted
- 30 Jun 2015
- Registered enrollment
- 40
- Registry id
- NCT01093222
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.